Survival after coronary artery bypass grafting. Experience from 4661 patients

E Ståhle1, R Bergström, L Holmberg

  • 1Department of Thoracic and Cardiovascular Surgery, University Hospital, Uppsala, Sweden.

European Heart Journal
|September 1, 1994
PubMed

Insights

Long-term survival after coronary artery bypass grafting (CABG) shows excess mortality risk increases significantly after 8 years. Early survival benefits diminish over time, highlighting the need for ongoing cardiovascular care.

Area of Science:

  • Cardiovascular Surgery
  • Outcomes Research
  • Epidemiology

Background:

  • Assessing long-term mortality after coronary artery bypass grafting (CABG) is crucial for patient management.
  • Excess mortality in CABG patients compared to the general population requires detailed temporal analysis.

Purpose of the Study:

  • To evaluate the duration of reduced mortality following CABG.
  • To analyze excess mortality trends in CABG patients over time relative to the general population.

Main Methods:

  • Survival analysis of 4661 patients undergoing first isolated CABG.
  • Calculation of relative survival using Swedish population data stratified by age, sex, and calendar period.
  • Multivariate modeling adjusted for age, surgery year, disease severity, left ventricular function, and smoking.

Main Results:

  • Relative survival rates were 94.6% at 5 years, 82.5% at 10 years, and 59.9% at 15 years.
  • Excess mortality risk (relative hazard) peaked around 8 years post-surgery, significantly increasing thereafter.
  • Smoking and pre-operative moderate/severe left ventricular dysfunction worsened relative survival.
  • Patients operated on after 1985 demonstrated higher survival rates.

Conclusions:

  • The mortality benefit of CABG diminishes significantly beyond 8 years post-operation.
  • Pre-operative factors like smoking and left ventricular function impact long-term survival.
  • Improvements in surgical timing and patient selection (post-1985) are associated with better long-term outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...